Search
Search
About
Log in
Join
Experiences with
Natalizumab
Posts
Communities
4 public posts
Filter results
Zumab
I was treated for MS for two years using
natalizumab
infusions. AKA Tysabri. I had to devise an acronym to help me remember. I came up with Natalie Merchant performing atop a Zumba, a disc-like vacuum cleaner that moves across the floor on its own.
I was treated for MS for two years using
natalizumab
infusions. AKA Tysabri. I had to devise an acronym to help me remember. I came up with Natalie Merchant performing atop a Zumba, a disc-like vacuum cleaner that moves across the floor on its own.
kaypeeoh
in
Cure Parkinson's
2 years ago
Antiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights & Diagnostic . .
Front Cell Neurosci. 2019; 13: 107.
Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107 A
ntiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges
Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
Front Cell Neurosci. 2019; 13: 107.
Published online 2019 Mar 19. doi: 10.3389/fncel.2019.00107 A
ntiphospholipid Antibodies Overlapping in Isolated Neurological Syndrome and Multiple Sclerosis: Neurobiological Insights and Diagnostic Challenges
Chiara D’Angelo,1,2,3 Oriol Franch,4 Lidia
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
4 years ago
Vaccines FYI
Some MS therapies, including steroids and disease-modifying therapies like Lemtrada (alemtuzumab), Tysabri (
natalizumab
), and Gilenya (fingolimod), are associated with diminished effectiveness of vaccines and a risk of infection as well.
Some MS therapies, including steroids and disease-modifying therapies like Lemtrada (alemtuzumab), Tysabri (
natalizumab
), and Gilenya (fingolimod), are associated with diminished effectiveness of vaccines and a risk of infection as well.
sashaming1
in
My MSAA Community
5 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
New MS biomarker
Serum NfL levels were higher for patients starting
natalizumab
and rituximab compared with those starting interferon, glatiramer acetate, and fingolimod. The levels decreased over time with all of these treatments.
Serum NfL levels were higher for patients starting
natalizumab
and rituximab compared with those starting interferon, glatiramer acetate, and fingolimod. The levels decreased over time with all of these treatments.
erash
in
My MSAA Community
7 years ago
Filter results
Clear filters
Posted in
All communities
My MSAA Community
2 results
Cure Parkinson's
1 result
LUpus Patients Understanding and Support
1 result
Sort by
Most Relevant
Newest